Lower courts “relied at every stage on patently unreliable witnesses and studies,” the ACLU said in its amicus brief.
By Chris Walker, TRUTHOUT
An amicus brief — or “friend of the court” petition — submitted to the U.S. Supreme Court by the American Civil Liberties Union (ACLU) urges justices of the High Court to reject lower court orders that have sought to severely curtail access to abortion medication known as mifepristone.
The drug is used in a majority of abortions across the country, and is currently approved for up to 10 weeks of pregnancy. Deregulation of its use during the COVID-19 pandemic (and following the Court’s overturn of Roe v. Wade in June 2022) allowed for the drug to be more widely available, permitting doctors to prescribe it through telemedicine and letting it be sent to patients through the mail.
However, actions by a far right federal judge in Texas, as well as affirmation of parts of that judgment from a conservative appellate court, now threaten access to the drug for those who want or need it. Both opinions, the ACLU writes in its brief to the Supreme Court, were based on “junk science.”
Recent Posts
In Southern Lebanon, Residents Fight Israeli Occupation
February 5, 2025
Take Action NowBarred from returning home, displaced civilians from southern Lebanon are setting up camps outside their villages where Israeli…
Trump’s Anti-Immigrant Blitz, a Zero Hour Conversation with Sonali Kolhatkar
February 5, 2025
Take Action Now Richard and Sonali criticize the misinformation spread by the administration, noting that many arrests are non-violent or involve…
‘A Day Without Immigrants’: Protests Against Trump’s Mass Deportation Plans Across U.S.
February 4, 2025
Take Action Now “D.C. depends deeply on immigrants, who work vital jobs in our local economy, pay taxes, and make the city a vibrant place to…
Fed Employee Unions Sue Over Musk’s Government Takeover
February 4, 2025
Take Action Now“It is disgraceful that the Trump administration has allowed unelected billionaires and their lackeys unfettered access to…